Ceterix Orthopaedics’ NovoStitch Pro is complementary to Smith & Nephew’s FAST-FIX 360 Meniscal Repair System. Credit: Smith & Nephew.

Smith & Nephew has agreed to purchase US-based medical device developer Ceterix Orthopaedics in a bid to expand its meniscal repair portfolio.

British medical technology company Smith & Nephew will initially pay $50m in cash and up to $55m over the next five years depending on financial performance.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Ceterix Orthopaedics is focussed on meniscal preservation. Its NovoStitch Pro Meniscal Repair System is designed to help address complex meniscal tear patterns.

Surgeons can use NovoStitch Pro to arthroscopically repair a variety of meniscal tear types such as horizontal, radial, complex, bucket handle, root and vertical tears.

The device is expected to complement Smith & Nephew’s FAST-FIX 360 Meniscal Repair System, which is used for treating vertical tears.

“We are proud of the impact our technology has made in developing the meniscal repair market and are excited by the opportunity to reach many more customers.”

Smith & Nephew sports medicine and ENT president Brad Cannon said: “NovoStitch Pro is an outstanding technology that addresses an unmet clinical need.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“We are excited by the opportunities to take this new option to our customers. No other company is better positioned to support changing clinical practice as the standard for meniscal treatment pivots from resection to repair.”

Smith & Nephew intends to commercialise the NovoStitch Pro device through its sports medicine sales force, as well as Ceterix Orthopaedics’ existing dedicated sales force.

Ceterix Orthopaedics CEO John McCutcheon said: “We are proud of the impact our technology has made in developing the meniscal repair market and are excited by the opportunity to reach many more customers and their patients as an integrated part of Smith & Nephew’s extensive portfolio.”

The acquisition is subject to customary conditions and is set to be completed early next year.

Smith & Nephew signed a similar agreement in October last year to takeover US-based tissue regeneration technology developer Rotation Medical.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact